An imminent danger is a workplace hazard that puts you at an immediate risk of death or serious physical harm. It may be a safety hazard, such as an unstable trench or an exposed electrical wire, or it may be a health hazard, such as toxic substances, dangerous fumes, dusts or gases. These dangers could cause irreversible physical harm, death or reduced physical or mental performance.

Encountering an Imminent Danger

If a safety or health hazard puts you in imminent danger of death, serious injury or illness, notify your supervisor immediately and request a corrective action to the problem. Also request that you get protection from the hazard until it is eliminated or controlled.

How You Are Protected

The Occupational Safety and Health Administration (OSHA) and the National Labor Relations Board work together to protect employees who are punished for refusing to work in imminently dangerous situations that involve serious safety and health hazards. In addition, OSHA can provide assistance if you are discharged or disciplined for refusing to do work that would expose you to imminent danger, providing that you notified your supervisor of the hazard, the hazard has not been corrected, and there is not enough time for you to seek relief through OSHA’s standard complaint process.

No Consequences

In addition, it is illegal for your employer to punish you for reporting a safety or health hazard under the Occupational Safety and Health Act (OSH Act). This law protects you from being discriminated against, fired, demoted or otherwise penalized for any of the following:

  • Complaining to your supervisor about a hazard
  • Requesting an OSHA inspection
  • Participating in union safety and health activities
  • Otherwise exercising your rights under the OSH Act

If Your Rights Are Violated

If you believe that your rights have been violated, you must file a complaint with OSHA within 30 days of the incident. OSHA can then work with your employer to restore your job, earnings and benefits. You will also not have to pay any legal fees.

For further construction and risk management resources, contact INSURICA today.

This is not intended to be exhaustive nor should any discussion or opinions be construed as legal advice. Readers should contact legal counsel or an insurance professional for appropriate advice. ©2024 Zywave, Inc. All rights reserved

About the Author

INSURICA
INSURICA

Share This Story

Stay Updated

Subscribe to the INSURICA blog and receive the latest news direct to your inbox.

Related Blogs

Fiduciary Responsibilities for Employer Health Plans: What Employers Should Know Now

March 6th, 2026|Blog, Employee Benefits|

When employers think about fiduciary responsibility, retirement plans often come to mind first. But recent developments make it clear that fiduciary duties also matter—sometimes significantly—when it comes to employer-sponsored health and welfare plans.

The New Era of Mental Health Parity Enforcement in 2026

March 5th, 2026|Blog, Employee Benefits|

Federal agencies have made mental health parity enforcement a top priority in 2026, and employers sponsoring group health plans are feeling the impact. Regulators are no longer satisfied with high‑level assurances that plans comply with the Mental Health Parity and Addiction Equity Act (MHPAEA). Instead, they expect detailed, data‑driven documentation showing that mental health and substance‑use‑disorder benefits are truly comparable to medical and surgical benefits. This includes not only the written plan design but also how rules are applied in real‑world scenarios.

The 2026 Specialty Drug Surge: What Employers Need to Prepare For

March 3rd, 2026|Blog, Employee Benefits|

Specialty drugs have been a major cost driver for years, but 2026 marks a significant shift in both scale and urgency. With GLP 1 medications expanding into new indications, gene therapies entering the market at record pace, and oncology drugs continuing to rise in both cost and utilization, specialty medications are projected to account for more than 60% of total pharmacy spending this year. That’s a dramatic change for employers, especially considering that specialty drugs represent fewer than 5% of total prescriptions.

Go to Top